CNBX Pharmaceuticals Inc.

CNBX Pharmaceuticals Inc. has reported zero cyber incidents and zero red-flag 8-K filings (bankruptcy, delisting, restatement, or officer departures) over the past 90 days. This clean near-term signal provides baseline reassurance, though a 90-day window captures limited operational history. The full $49 Report extends analysis to 12 months of SEC filings, adds dilution risk scoring, financing history context, and AI-detected risk signals that may not yet surface in traditional alerts. The full $49 Report adds comprehensive dilution trajectory, capital structure analysis, and forward-looking risk patterns across the full fiscal year.